A latest report has been added to the wide database of Cell-Based Assays Market by Infinium Global Research. This report studies the
Cell-Based Assays Market by products & services (instruments, consumables, software and services), application (drug discovery, basic
research, predictive toxicology, ADME studies and other applications), end users (pharmaceutical & biotechnology companies, contract
research organizations, academic & government institutions and other end users) market status and outlook of global and major
regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of different segments &
countries in recent years and to forecast the values for the next six years. Cell-Based Assays Market provides opportunities in micro
markets for stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and product offerings of the
major companies in the Cell-Based Assays Market. According to report the global cell-based assays market is expected to grow at a
CAGR between 8.0% and 8.5 % over the forecast period of 2017 - 2023.
Consumablesare estimated to Account for the Largest Share of the Market in 2017
By product and service, the cell-based assays market is classified into instruments, consumables, software and services. The
consumables segment is expected to lead the global cell-based assays in 2017. Factors driving the growth of this segment include
increasing adoption of consumables in hospitals and clinical laboratories, rising incidence of chronic diseases, and increasing demand
for quick results.
Drug Discovery is estimated to Command the Largest Share of the Market during the Forecast Period
On the basis of application, the cell-based assays market is categorized into drug discovery, basic research, predictive toxicology, ADME
studies and other applications. The drug discovery segment is estimated to account for the largest share of the global cell-based assays
market during the forecast period. Increasing demand for new drugs from the end use industries as well as growing use of cell-based
assays for drug development over traditional techniques is the key factor driving the growth of this application segment.
North America is estimated to Command the Largest Share of the Market
Based on region, the cell-based assays market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North
America is expected to dominate the cell-based assays market in 2017. This is attributed to factors such as rising adoption of cell-based
assays platform as well as presence of number of pharmaceuticals industry in the region and growing investment in the research for
drug discovery across the region.